Recurrent and founder mutations in the Netherlands: the cardiac phenotype of founder mutations p.S13F and p.N342D

K. Y. van Spaendonck-Zwarts*, A. J. van der Kooi, M. P. van den Berg, E. F. Ippel, L. G. Boven, W. -C. Yee, A. van den Wijngaard, E. Brusse, J. E. Hoogendijk, P. A. Doevendans, M. de Visser, J. D. H. Jongbloed, J. P. van Tintelen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)

Abstract

Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (). We describe new families carrying the p.S13F or p.N342D mutations, the cardiac phenotype of all carriers, and the founder effects. We collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using genealogy and haplotype analysis. We identified three new index patients carrying the p.S13F mutation and two new families carrying the p.N342D mutation. In total, we summarised the clinical details of 39 p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardiac phenotype of p.S13F carriers is fully penetrant and severe, characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement. Although muscle weakness is a prominent and presenting symptom in p.N342D carriers, their cardiac phenotype is similar to that of p.S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haplotype analysis. DRM may occur as an apparently isolated cardiological disorder. The cardiac phenotypes of the founder mutations p.S13F and p.N342D are characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement.
Original languageEnglish
Pages (from-to)219-228
JournalNetherlands Heart Journal
Volume20
Issue number5
DOIs
Publication statusPublished - May 2012

Keywords

  • Desmin
  • Genetics
  • Founder mutation
  • Cardiomyopathy
  • Cardiac conduction disease

Cite this